Isis and Alnylam Launch Regulus Therapeutics, a Joint Venture to Discover, Develop, and Commercialize microRNA Therapeutics

News   Sep 10, 2007

 
Isis and Alnylam Launch Regulus Therapeutics, a Joint Venture to Discover, Develop, and Commercialize microRNA Therapeutics
 
 
 

RELATED ARTICLES

New Blood Test Developed to Diagnose Ovarian Cancer

News

Investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute are leveraging the power of artificial intelligence to develop a new technique to detect ovarian cancer early and accurately.

READ MORE

Horizon Discovery Partners with The Michael J. Fox Foundation

News

Innovative and relevant models for understanding alpha-synuclein biology and Parkinson’s disease pathogenesis in vivo.

READ MORE

Finding Drug Targets for Obesity, Diabetes

News

Technological breakthrough will likely be of great interest to biotechnology companies aspiring to build their drug pipeline in the metabolic disease area.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE